Last updated on January 2017

A Study to Assess Retention Rate Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation


Brief description of study

The objective of this study is to access retention rate, persistence and adherence in population of spondylarthritis (SpA) (ankylosing spondylitis (AS) and psoriatic arthritis (PsA)) participants treated with adalimumab in routine clinical settings in the Russian Federation.

Clinical Study Identifier: NCT02988674

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Site Reference ID/Investigator# 154381, MD

Site Reference ID/Investigator# 154381
Khanty-Mansiysk, Russian Federation
  Connect »